7Baggers

Takeda Pharmaceutical Quarterly Income Statements Chart

Quarterly
 | 
Annual
 
 Revenue  
 Gross Profit  
 Operating Profit  
 Net Income  
20190331 20190630 20190930 20191231 20200331 20200630 20200930 20201231 20210331 20210630 20210930 20211231 20220331 20220630 20220930 20221231 20230331 20230630 20230930 20231231 -79.4590.64260.73430.82600.91771941.11,111.19Billion

Takeda Pharmaceutical Quarterly Income Statements Table

Quarterly
 | 
Annual
 
Unit: USD2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-03-31 2008-12-31 2008-09-30 
  revenue1,111,186,000,000 1,043,089,000,000 1,058,618,000,000 956,156,000,000 1,096,551,000,000 1,002,307,000,000 972,465,000,000 873,289,000,000 901,294,000,000 844,819,000,000 949,603,000,000 770,274,000,000 836,753,000,000 788,935,000,000 801,850,000,000 771,702,000,000 859,317,000,000 811,048,000,000 849,121,000,000 717,211,000,000 499,402,000,000 430,777,000,000 449,834,000,000 400,963,000,000 488,151,000,000 433,177,000,000 448,240,000,000 416,205,000,000 465,045,000,000 416,795,000,000 434,005,000,000 414,121,000,000 489,208,000,000 457,754,000,000 446,295,000,000 437,839,000,000 488,633,000,000 440,204,000,000 411,148,000,000 404,810,000,000 458,821,000,000 417,739,000,000 410,302,000,000 368,158,000,000 402,173,000,000 388,644,000,000 398,292,000,000 381,324,000,000 425,106,000,000 345,283,000,000 357,219,000,000 338,255,000,000 367,105,000,000 359,327,000,000 354,698,000,000 338,019,000,000 372,493,000,000 376,476,000,000 378,977,000,000 335,576,000,000 395,620,000,000 410,259,000,000 
  cost of revenue379,481,000,000 343,582,000,000 321,114,000,000 309,772,000,000 335,973,000,000 305,445,000,000 292,882,000,000 308,380,000,000 281,404,000,000 275,797,000,000 241,264,000,000 253,446,000,000 253,142,000,000 249,642,000,000 238,078,000,000 248,181,000,000 279,575,000,000 271,710,000,000 300,592,000,000 289,835,000,000 138,514,000,000 110,751,000,000 120,590,000,000 110,892,000,000 142,287,000,000 121,873,000,000 120,868,000,000 134,407,000,000 147,490,000,000 141,462,000,000 135,395,000,000 132,965,000,000 145,026,000,000 136,293,000,000 121,121,000,000 134,583,000,000 139,420,000,000 128,948,000,000 118,039,000,000 130,943,000,000 131,537,000,000 120,137,000,000 115,091,000,000 111,072,000,000 120,496,000,000 112,747,000,000 103,313,000,000 128,175,000,000 145,454,000,000 80,665,000,000 78,900,000,000 82,887,000,000 84,112,000,000 77,481,000,000 73,102,000,000 70,435,000,000 74,248,000,000 69,046,000,000 71,336,000,000 68,273,000,000 70,562,000,000 72,081,000,000 
  gross profit731,705,000,000 699,507,000,000 737,504,000,000 646,384,000,000 760,578,000,000 696,862,000,000 679,583,000,000 564,909,000,000 619,890,000,000 569,022,000,000 708,339,000,000 516,828,000,000 583,611,000,000 539,293,000,000 563,772,000,000 523,521,000,000 579,742,000,000 539,338,000,000 548,529,000,000 427,376,000,000 360,888,000,000 320,026,000,000 329,244,000,000 290,071,000,000 345,864,000,000 311,304,000,000 327,372,000,000 281,798,000,000 317,555,000,000 275,333,000,000 298,610,000,000 281,156,000,000 344,182,000,000 321,461,000,000 325,174,000,000 303,256,000,000 349,213,000,000 311,256,000,000 293,109,000,000 273,867,000,000 327,284,000,000 297,602,000,000 295,211,000,000 257,086,000,000 281,677,000,000 275,897,000,000 294,979,000,000 253,149,000,000 279,652,000,000 264,618,000,000 278,319,000,000 255,368,000,000 282,993,000,000 281,846,000,000 281,596,000,000 267,584,000,000 298,245,000,000 307,430,000,000 307,641,000,000 267,303,000,000 325,058,000,000 338,178,000,000 
  operating expenses                                                              
  research and development187,381,000,000 183,946,000,000 162,741,000,000 160,944,000,000 174,629,000,000 154,145,000,000 143,607,000,000 143,628,000,000 128,378,000,000 131,600,000,000 122,480,000,000 113,289,000,000 117,566,000,000 118,157,000,000 106,821,000,000 139,309,000,000 122,709,000,000 113,497,000,000 116,866,000,000 139,405,000,000 77,461,000,000 79,466,000,000 71,966,000,000 88,782,000,000 81,564,000,000 79,408,000,000 75,688,000,000 88,504,000,000 71,833,000,000 75,416,000,000 76,550,000,000 92,029,000,000 92,525,000,000 80,382,000,000 80,991,000,000 132,869,000,000 92,708,000,000 81,363,000,000 75,155,000,000 103,366,000,000 83,105,000,000 76,641,000,000 77,546,000,000 76,897,000,000 75,799,000,000 78,878,000,000 70,737,000,000 61,286,000,000 57,715,000,000 65,806,000,000 62,082,000,000 62,113,000,000 73,698,000,000 70,714,000,000 64,867,000,000 56,531,000,000 86,237,000,000 
  sales, general and administrative                                                              
  total operating expenses665,290,000,000 748,850,000,000 568,933,000,000 557,820,000,000 613,588,000,000 592,425,000,000 529,067,000,000 566,527,000,000 503,405,000,000 471,595,000,000 459,787,000,000 366,288,000,000 440,470,000,000 490,990,000,000 396,487,000,000 585,657,000,000 526,231,000,000 498,894,000,000 538,663,000,000 551,431,000,000 248,424,000,000 246,940,000,000 230,374,000,000 370,569,000,000 257,925,000,000 271,929,000,000 132,397,000,000 343,361,000,000 262,200,000,000 266,190,000,000 145,677,000,000 317,809,000,000 287,152,000,000 260,571,000,000 275,616,000,000 631,562,000,000 266,856,000,000 258,249,000,000 229,421,000,000 303,951,000,000 260,497,000,000 244,899,000,000 247,506,000,000 285,253,000,000 547,204,000,000 75,799,000,000 78,878,000,000 620,973,000,000 70,737,000,000 61,286,000,000 57,715,000,000 544,717,000,000 65,806,000,000 62,082,000,000 62,112,000,000 551,412,000,000 73,698,000,000 70,713,000,000 64,868,000,000 564,727,000,000 56,531,000,000 86,238,000,000 
  operating income104,914,000,000 -49,341,000,000 168,571,000,000 88,562,000,000 146,990,000,000 104,438,000,000 210,942,000,000 -30,979,000,000 116,484,000,000 97,427,000,000 248,552,000,000 150,540,000,000 143,141,000,000 48,303,000,000 167,285,000,000 -62,136,000,000 53,511,000,000 40,444,000,000 9,866,000,000 -79,451,000,000 112,464,000,000 73,086,000,000 98,870,000,000 -80,498,000,000 87,938,000,000 39,374,000,000 194,975,000,000 -61,563,000,000 55,354,000,000 9,143,000,000 152,933,000,000 -36,652,000,000 57,030,000,000 60,890,000,000 49,559,000,000 -328,306,000,000 82,357,000,000 53,006,000,000 63,689,000,000 -30,083,000,000 66,788,000,000 52,703,000,000 47,705,000,000 -28,167,000,000 -265,527,000,000 200,098,000,000 216,101,000,000 -367,824,000,000 208,915,000,000 203,332,000,000 220,604,000,000 -289,349,000,000 217,187,000,000 219,764,000,000 219,484,000,000 -283,828,000,000 224,547,000,000 236,717,000,000 242,773,000,000 -297,424,000,000 268,527,000,000 251,940,000,000 
  net income105,720,000,000 -48,030,000,000 89,395,000,000 31,134,000,000 119,127,000,000 61,742,000,000 105,014,000,000 -11,375,000,000 57,770,000,000 45,964,000,000 137,684,000,000 197,098,000,000 92,359,000,000 4,037,000,000 82,511,000,000 1,724,000,000 -32,221,000,000 53,844,000,000 -20,660,000,000 -55,308,000,000 37,766,000,000 48,426,000,000 78,242,000,000 -54,020,000,000 68,089,000,000 28,028,000,000 144,789,000,000 -50,734,000,000 41,374,000,000 24,773,000,000 99,527,000,000 -33,480,000,000 59,260,000,000 29,802,000,000 24,583,000,000 -225,520,000,000 18,308,000,000 28,037,000,000 33,399,000,000 -4,340,000,000 54,532,000,000 42,804,000,000 29,076,000,000 -7,668,000,000 19,122,000,000 32,227,000,000 87,563,000,000 -36,445,000,000 24,947,000,000 60,076,000,000 75,584,000,000 32,376,000,000 71,280,000,000 80,100,000,000 64,111,000,000 38,595,000,000 69,515,000,000 77,040,000,000 112,594,000,000 65,812,000,000 96,785,000,000 69,294,000,000 

We provide you with 20 years income statements for Takeda Pharmaceutical stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Takeda Pharmaceutical stock. Explore the full financial landscape of Takeda Pharmaceutical stock with our expertly curated income statements.

The information provided in this report about Takeda Pharmaceutical stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.